nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP1B1—ovarian cancer	0.489	1	CbGaD
Propofol—CYP1B1—Paclitaxel—ovarian cancer	0.0761	0.265	CbGbCtD
Propofol—CYP1B1—Docetaxel—ovarian cancer	0.055	0.192	CbGbCtD
Propofol—CYP1B1—Doxorubicin—ovarian cancer	0.041	0.143	CbGbCtD
Propofol—CYP2C8—Paclitaxel—ovarian cancer	0.0193	0.0671	CbGbCtD
Propofol—CYP2D6—Vinorelbine—ovarian cancer	0.0175	0.0609	CbGbCtD
Propofol—CYP3A4—Topotecan—ovarian cancer	0.0158	0.055	CbGbCtD
Propofol—CYP2B6—Doxorubicin—ovarian cancer	0.0137	0.0477	CbGbCtD
Propofol—CYP2C9—Paclitaxel—ovarian cancer	0.0134	0.0468	CbGbCtD
Propofol—CYP3A4—Vinorelbine—ovarian cancer	0.0111	0.0387	CbGbCtD
Propofol—CYP3A4—Paclitaxel—ovarian cancer	0.00782	0.0272	CbGbCtD
Propofol—CYP2D6—Doxorubicin—ovarian cancer	0.00662	0.0231	CbGbCtD
Propofol—CYP3A4—Docetaxel—ovarian cancer	0.00565	0.0197	CbGbCtD
Propofol—CYP3A4—Doxorubicin—ovarian cancer	0.00421	0.0147	CbGbCtD
Propofol—UGT1A6—testis—ovarian cancer	0.00145	0.0563	CbGeAlD
Propofol—FAAH—decidua—ovarian cancer	0.00141	0.0548	CbGeAlD
Propofol—FAAH—endometrium—ovarian cancer	0.00134	0.052	CbGeAlD
Propofol—FAAH—gonad—ovarian cancer	0.00124	0.0482	CbGeAlD
Propofol—CYP2C18—uterine cervix—ovarian cancer	0.00113	0.0439	CbGeAlD
Propofol—FAAH—female reproductive system—ovarian cancer	0.00111	0.0431	CbGeAlD
Propofol—FAAH—female gonad—ovarian cancer	0.00101	0.0392	CbGeAlD
Propofol—FAAH—vagina—ovarian cancer	0.001	0.039	CbGeAlD
Propofol—FAAH—testis—ovarian cancer	0.000894	0.0348	CbGeAlD
Propofol—CYP2C18—vagina—ovarian cancer	0.000765	0.0298	CbGeAlD
Propofol—FAAH—lymph node—ovarian cancer	0.000648	0.0252	CbGeAlD
Propofol—SCN4A—testis—ovarian cancer	0.000581	0.0226	CbGeAlD
Propofol—SCN2A—vagina—ovarian cancer	0.000576	0.0224	CbGeAlD
Propofol—CYP1B1—decidua—ovarian cancer	0.000521	0.0203	CbGeAlD
Propofol—CYP2A6—vagina—ovarian cancer	0.000506	0.0197	CbGeAlD
Propofol—GABRB3—gonad—ovarian cancer	0.000465	0.0181	CbGeAlD
Propofol—CYP1B1—gonad—ovarian cancer	0.000459	0.0179	CbGeAlD
Propofol—CYP1B1—uterus—ovarian cancer	0.000456	0.0177	CbGeAlD
Propofol—GABRA2—vagina—ovarian cancer	0.000447	0.0174	CbGeAlD
Propofol—GABRB2—testis—ovarian cancer	0.000437	0.017	CbGeAlD
Propofol—GABRB3—female reproductive system—ovarian cancer	0.000415	0.0162	CbGeAlD
Propofol—CYP1B1—female reproductive system—ovarian cancer	0.00041	0.0159	CbGeAlD
Propofol—CYP1A1—epithelium—ovarian cancer	0.00039	0.0152	CbGeAlD
Propofol—CYP1A1—uterine cervix—ovarian cancer	0.000387	0.015	CbGeAlD
Propofol—CYP2C8—endometrium—ovarian cancer	0.000379	0.0147	CbGeAlD
Propofol—CYP1B1—female gonad—ovarian cancer	0.000373	0.0145	CbGeAlD
Propofol—ALB—testis—ovarian cancer	0.000361	0.014	CbGeAlD
Propofol—GABRB3—testis—ovarian cancer	0.000335	0.013	CbGeAlD
Propofol—CYP1B1—testis—ovarian cancer	0.000331	0.0129	CbGeAlD
Propofol—CYP2C19—vagina—ovarian cancer	0.000325	0.0127	CbGeAlD
Propofol—CYP1A1—uterus—ovarian cancer	0.000322	0.0125	CbGeAlD
Propofol—CYP2B6—gonad—ovarian cancer	0.000315	0.0123	CbGeAlD
Propofol—CYP2C8—female reproductive system—ovarian cancer	0.000314	0.0122	CbGeAlD
Propofol—CYP1A1—female reproductive system—ovarian cancer	0.00029	0.0113	CbGeAlD
Propofol—GABRA2—lymph node—ovarian cancer	0.000289	0.0112	CbGeAlD
Propofol—CYP2C8—vagina—ovarian cancer	0.000284	0.011	CbGeAlD
Propofol—CYP2B6—female reproductive system—ovarian cancer	0.000282	0.011	CbGeAlD
Propofol—CYP2C9—female reproductive system—ovarian cancer	0.000279	0.0108	CbGeAlD
Propofol—CYP2E1—female reproductive system—ovarian cancer	0.000264	0.0103	CbGeAlD
Propofol—CYP1A1—female gonad—ovarian cancer	0.000264	0.0103	CbGeAlD
Propofol—CYP1A1—vagina—ovarian cancer	0.000262	0.0102	CbGeAlD
Propofol—ALB—lymph node—ovarian cancer	0.000261	0.0102	CbGeAlD
Propofol—CYP2B6—vagina—ovarian cancer	0.000255	0.00991	CbGeAlD
Propofol—CYP2C8—testis—ovarian cancer	0.000253	0.00986	CbGeAlD
Propofol—CYP1B1—lymph node—ovarian cancer	0.00024	0.00933	CbGeAlD
Propofol—CYP2B6—testis—ovarian cancer	0.000227	0.00884	CbGeAlD
Propofol—Abnormal vision—Doxorubicin—ovarian cancer	0.000217	0.00151	CcSEcCtD
Propofol—Eye pain—Epirubicin—ovarian cancer	0.000217	0.0015	CcSEcCtD
Propofol—Sepsis—Doxorubicin—ovarian cancer	0.000216	0.0015	CcSEcCtD
Propofol—Mental disability—Doxorubicin—ovarian cancer	0.000216	0.0015	CcSEcCtD
Propofol—Fatigue—Vinorelbine—ovarian cancer	0.000216	0.00149	CcSEcCtD
Propofol—Pain—Vinorelbine—ovarian cancer	0.000214	0.00148	CcSEcCtD
Propofol—CYP2E1—testis—ovarian cancer	0.000213	0.0083	CbGeAlD
Propofol—CYP3A4—female reproductive system—ovarian cancer	0.000213	0.00827	CbGeAlD
Propofol—Chills—Paclitaxel—ovarian cancer	0.000212	0.00147	CcSEcCtD
Propofol—Arrhythmia—Paclitaxel—ovarian cancer	0.000211	0.00146	CcSEcCtD
Propofol—Phlebitis—Doxorubicin—ovarian cancer	0.00021	0.00145	CcSEcCtD
Propofol—Asthenia—Topotecan—ovarian cancer	0.00021	0.00145	CcSEcCtD
Propofol—CYP2D6—female reproductive system—ovarian cancer	0.000209	0.00814	CbGeAlD
Propofol—Vomiting—Chlorambucil—ovarian cancer	0.000209	0.00144	CcSEcCtD
Propofol—Pruritus—Topotecan—ovarian cancer	0.000207	0.00143	CcSEcCtD
Propofol—Erythema—Paclitaxel—ovarian cancer	0.000206	0.00143	CcSEcCtD
Propofol—Feeling abnormal—Vinorelbine—ovarian cancer	0.000206	0.00143	CcSEcCtD
Propofol—Asthenia—Melphalan—ovarian cancer	0.000205	0.00142	CcSEcCtD
Propofol—Pruritus—Melphalan—ovarian cancer	0.000202	0.0014	CcSEcCtD
Propofol—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000202	0.0014	CcSEcCtD
Propofol—Dysgeusia—Paclitaxel—ovarian cancer	0.000202	0.0014	CcSEcCtD
Propofol—Haemoglobin—Docetaxel—ovarian cancer	0.000202	0.0014	CcSEcCtD
Propofol—Haemorrhage—Docetaxel—ovarian cancer	0.000201	0.00139	CcSEcCtD
Propofol—Eye pain—Doxorubicin—ovarian cancer	0.000201	0.00139	CcSEcCtD
Propofol—Cardiac failure—Epirubicin—ovarian cancer	0.0002	0.00139	CcSEcCtD
Propofol—Diarrhoea—Topotecan—ovarian cancer	0.0002	0.00138	CcSEcCtD
Propofol—Pharyngitis—Docetaxel—ovarian cancer	0.000199	0.00138	CcSEcCtD
Propofol—Urticaria—Vinorelbine—ovarian cancer	0.000199	0.00137	CcSEcCtD
Propofol—Muscle spasms—Paclitaxel—ovarian cancer	0.000198	0.00137	CcSEcCtD
Propofol—Body temperature increased—Vinorelbine—ovarian cancer	0.000198	0.00137	CcSEcCtD
Propofol—Abdominal pain—Vinorelbine—ovarian cancer	0.000198	0.00137	CcSEcCtD
Propofol—Diarrhoea—Melphalan—ovarian cancer	0.000196	0.00136	CcSEcCtD
Propofol—Pain in extremity—Epirubicin—ovarian cancer	0.000196	0.00135	CcSEcCtD
Propofol—Diplopia—Epirubicin—ovarian cancer	0.000196	0.00135	CcSEcCtD
Propofol—Nausea—Chlorambucil—ovarian cancer	0.000195	0.00135	CcSEcCtD
Propofol—Visual impairment—Docetaxel—ovarian cancer	0.000193	0.00134	CcSEcCtD
Propofol—Dizziness—Topotecan—ovarian cancer	0.000193	0.00134	CcSEcCtD
Propofol—Tremor—Paclitaxel—ovarian cancer	0.000193	0.00134	CcSEcCtD
Propofol—Affect lability—Epirubicin—ovarian cancer	0.000193	0.00133	CcSEcCtD
Propofol—CYP2D6—female gonad—ovarian cancer	0.00019	0.00741	CbGeAlD
Propofol—Agitation—Paclitaxel—ovarian cancer	0.000189	0.00131	CcSEcCtD
Propofol—Angioedema—Paclitaxel—ovarian cancer	0.000188	0.0013	CcSEcCtD
Propofol—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000187	0.00129	CcSEcCtD
Propofol—Flushing—Docetaxel—ovarian cancer	0.000186	0.00129	CcSEcCtD
Propofol—Cardiac arrest—Epirubicin—ovarian cancer	0.000186	0.00129	CcSEcCtD
Propofol—Vomiting—Topotecan—ovarian cancer	0.000186	0.00129	CcSEcCtD
Propofol—Cardiac failure—Doxorubicin—ovarian cancer	0.000185	0.00128	CcSEcCtD
Propofol—Mood swings—Epirubicin—ovarian cancer	0.000185	0.00128	CcSEcCtD
Propofol—Syncope—Paclitaxel—ovarian cancer	0.000185	0.00128	CcSEcCtD
Propofol—Rash—Topotecan—ovarian cancer	0.000184	0.00128	CcSEcCtD
Propofol—Dermatitis—Topotecan—ovarian cancer	0.000184	0.00127	CcSEcCtD
Propofol—Blood creatinine increased—Epirubicin—ovarian cancer	0.000183	0.00127	CcSEcCtD
Propofol—Headache—Topotecan—ovarian cancer	0.000183	0.00127	CcSEcCtD
Propofol—Vomiting—Melphalan—ovarian cancer	0.000182	0.00126	CcSEcCtD
Propofol—Dehydration—Epirubicin—ovarian cancer	0.000182	0.00126	CcSEcCtD
Propofol—Loss of consciousness—Paclitaxel—ovarian cancer	0.000181	0.00125	CcSEcCtD
Propofol—Pain in extremity—Doxorubicin—ovarian cancer	0.000181	0.00125	CcSEcCtD
Propofol—Diplopia—Doxorubicin—ovarian cancer	0.000181	0.00125	CcSEcCtD
Propofol—Rash—Melphalan—ovarian cancer	0.00018	0.00125	CcSEcCtD
Propofol—Dermatitis—Melphalan—ovarian cancer	0.00018	0.00125	CcSEcCtD
Propofol—Chills—Docetaxel—ovarian cancer	0.00018	0.00125	CcSEcCtD
Propofol—Cough—Paclitaxel—ovarian cancer	0.00018	0.00124	CcSEcCtD
Propofol—Asthenia—Vinorelbine—ovarian cancer	0.000179	0.00124	CcSEcCtD
Propofol—Arrhythmia—Docetaxel—ovarian cancer	0.000179	0.00124	CcSEcCtD
Propofol—Convulsion—Paclitaxel—ovarian cancer	0.000179	0.00124	CcSEcCtD
Propofol—Affect lability—Doxorubicin—ovarian cancer	0.000178	0.00123	CcSEcCtD
Propofol—Hypertension—Paclitaxel—ovarian cancer	0.000178	0.00123	CcSEcCtD
Propofol—Pruritus—Vinorelbine—ovarian cancer	0.000177	0.00122	CcSEcCtD
Propofol—Chest pain—Paclitaxel—ovarian cancer	0.000175	0.00121	CcSEcCtD
Propofol—Myalgia—Paclitaxel—ovarian cancer	0.000175	0.00121	CcSEcCtD
Propofol—Anxiety—Paclitaxel—ovarian cancer	0.000175	0.00121	CcSEcCtD
Propofol—Erythema—Docetaxel—ovarian cancer	0.000175	0.00121	CcSEcCtD
Propofol—Nausea—Topotecan—ovarian cancer	0.000174	0.0012	CcSEcCtD
Propofol—Cardiac arrest—Doxorubicin—ovarian cancer	0.000172	0.00119	CcSEcCtD
Propofol—Dry mouth—Paclitaxel—ovarian cancer	0.000172	0.00119	CcSEcCtD
Propofol—Mood swings—Doxorubicin—ovarian cancer	0.000171	0.00119	CcSEcCtD
Propofol—Diarrhoea—Vinorelbine—ovarian cancer	0.000171	0.00118	CcSEcCtD
Propofol—Dysgeusia—Docetaxel—ovarian cancer	0.000171	0.00118	CcSEcCtD
Propofol—Nausea—Melphalan—ovarian cancer	0.00017	0.00118	CcSEcCtD
Propofol—Confusional state—Paclitaxel—ovarian cancer	0.00017	0.00117	CcSEcCtD
Propofol—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00017	0.00117	CcSEcCtD
Propofol—CYP1A1—lymph node—ovarian cancer	0.00017	0.00659	CbGeAlD
Propofol—CYP2D6—testis—ovarian cancer	0.000169	0.00657	CbGeAlD
Propofol—Dehydration—Doxorubicin—ovarian cancer	0.000168	0.00117	CcSEcCtD
Propofol—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000168	0.00116	CcSEcCtD
Propofol—Oedema—Paclitaxel—ovarian cancer	0.000168	0.00116	CcSEcCtD
Propofol—Muscle spasms—Docetaxel—ovarian cancer	0.000168	0.00116	CcSEcCtD
Propofol—Pancreatitis—Epirubicin—ovarian cancer	0.000166	0.00115	CcSEcCtD
Propofol—Shock—Paclitaxel—ovarian cancer	0.000165	0.00115	CcSEcCtD
Propofol—Dizziness—Vinorelbine—ovarian cancer	0.000165	0.00114	CcSEcCtD
Propofol—Tachycardia—Paclitaxel—ovarian cancer	0.000164	0.00114	CcSEcCtD
Propofol—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000163	0.00113	CcSEcCtD
Propofol—Vomiting—Vinorelbine—ovarian cancer	0.000159	0.0011	CcSEcCtD
Propofol—Rash—Vinorelbine—ovarian cancer	0.000158	0.00109	CcSEcCtD
Propofol—Dermatitis—Vinorelbine—ovarian cancer	0.000158	0.00109	CcSEcCtD
Propofol—Hypotension—Paclitaxel—ovarian cancer	0.000157	0.00109	CcSEcCtD
Propofol—Headache—Vinorelbine—ovarian cancer	0.000157	0.00108	CcSEcCtD
Propofol—Syncope—Docetaxel—ovarian cancer	0.000157	0.00108	CcSEcCtD
Propofol—Loss of consciousness—Docetaxel—ovarian cancer	0.000154	0.00106	CcSEcCtD
Propofol—Pancreatitis—Doxorubicin—ovarian cancer	0.000153	0.00106	CcSEcCtD
Propofol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000153	0.00106	CcSEcCtD
Propofol—Hyperglycaemia—Epirubicin—ovarian cancer	0.000153	0.00106	CcSEcCtD
Propofol—Cough—Docetaxel—ovarian cancer	0.000152	0.00105	CcSEcCtD
Propofol—Insomnia—Paclitaxel—ovarian cancer	0.000152	0.00105	CcSEcCtD
Propofol—Convulsion—Docetaxel—ovarian cancer	0.000151	0.00105	CcSEcCtD
Propofol—Paraesthesia—Paclitaxel—ovarian cancer	0.000151	0.00105	CcSEcCtD
Propofol—Hypertension—Docetaxel—ovarian cancer	0.000151	0.00104	CcSEcCtD
Propofol—Dyspnoea—Paclitaxel—ovarian cancer	0.00015	0.00104	CcSEcCtD
Propofol—Somnolence—Paclitaxel—ovarian cancer	0.00015	0.00103	CcSEcCtD
Propofol—Chest pain—Docetaxel—ovarian cancer	0.000149	0.00103	CcSEcCtD
Propofol—Myalgia—Docetaxel—ovarian cancer	0.000149	0.00103	CcSEcCtD
Propofol—Nausea—Vinorelbine—ovarian cancer	0.000149	0.00103	CcSEcCtD
Propofol—Renal failure—Epirubicin—ovarian cancer	0.000148	0.00103	CcSEcCtD
Propofol—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000148	0.00102	CcSEcCtD
Propofol—Dry mouth—Docetaxel—ovarian cancer	0.000145	0.00101	CcSEcCtD
Propofol—Fatigue—Paclitaxel—ovarian cancer	0.000145	0.001	CcSEcCtD
Propofol—Pain—Paclitaxel—ovarian cancer	0.000144	0.000995	CcSEcCtD
Propofol—Confusional state—Docetaxel—ovarian cancer	0.000144	0.000995	CcSEcCtD
Propofol—Anaphylactic shock—Docetaxel—ovarian cancer	0.000143	0.000987	CcSEcCtD
Propofol—Oedema—Docetaxel—ovarian cancer	0.000143	0.000987	CcSEcCtD
Propofol—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000141	0.000977	CcSEcCtD
Propofol—Shock—Docetaxel—ovarian cancer	0.00014	0.000971	CcSEcCtD
Propofol—Tachycardia—Docetaxel—ovarian cancer	0.000139	0.000963	CcSEcCtD
Propofol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000139	0.000959	CcSEcCtD
Propofol—Bradycardia—Epirubicin—ovarian cancer	0.000138	0.000954	CcSEcCtD
Propofol—Renal failure—Doxorubicin—ovarian cancer	0.000137	0.000949	CcSEcCtD
Propofol—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000137	0.000946	CcSEcCtD
Propofol—Haemoglobin—Epirubicin—ovarian cancer	0.000136	0.000942	CcSEcCtD
Propofol—Haemorrhage—Epirubicin—ovarian cancer	0.000135	0.000937	CcSEcCtD
Propofol—Pharyngitis—Epirubicin—ovarian cancer	0.000134	0.00093	CcSEcCtD
Propofol—Urticaria—Paclitaxel—ovarian cancer	0.000134	0.000925	CcSEcCtD
Propofol—Hypotension—Docetaxel—ovarian cancer	0.000133	0.000922	CcSEcCtD
Propofol—Abdominal pain—Paclitaxel—ovarian cancer	0.000133	0.00092	CcSEcCtD
Propofol—Body temperature increased—Paclitaxel—ovarian cancer	0.000133	0.00092	CcSEcCtD
Propofol—Visual impairment—Epirubicin—ovarian cancer	0.00013	0.000903	CcSEcCtD
Propofol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00013	0.000899	CcSEcCtD
Propofol—Insomnia—Docetaxel—ovarian cancer	0.000129	0.000892	CcSEcCtD
Propofol—Paraesthesia—Docetaxel—ovarian cancer	0.000128	0.000886	CcSEcCtD
Propofol—Bradycardia—Doxorubicin—ovarian cancer	0.000127	0.000882	CcSEcCtD
Propofol—Dyspnoea—Docetaxel—ovarian cancer	0.000127	0.00088	CcSEcCtD
Propofol—Somnolence—Docetaxel—ovarian cancer	0.000127	0.000877	CcSEcCtD
Propofol—Tinnitus—Epirubicin—ovarian cancer	0.000126	0.000873	CcSEcCtD
Propofol—Haemoglobin—Doxorubicin—ovarian cancer	0.000126	0.000871	CcSEcCtD
Propofol—Flushing—Epirubicin—ovarian cancer	0.000126	0.000869	CcSEcCtD
Propofol—Haemorrhage—Doxorubicin—ovarian cancer	0.000125	0.000867	CcSEcCtD
Propofol—Pharyngitis—Doxorubicin—ovarian cancer	0.000124	0.00086	CcSEcCtD
Propofol—Fatigue—Docetaxel—ovarian cancer	0.000123	0.000851	CcSEcCtD
Propofol—Pain—Docetaxel—ovarian cancer	0.000122	0.000844	CcSEcCtD
Propofol—Chills—Epirubicin—ovarian cancer	0.000121	0.000841	CcSEcCtD
Propofol—Arrhythmia—Epirubicin—ovarian cancer	0.000121	0.000837	CcSEcCtD
Propofol—Visual impairment—Doxorubicin—ovarian cancer	0.000121	0.000835	CcSEcCtD
Propofol—Asthenia—Paclitaxel—ovarian cancer	0.000121	0.000835	CcSEcCtD
Propofol—Pruritus—Paclitaxel—ovarian cancer	0.000119	0.000824	CcSEcCtD
Propofol—Erythema—Epirubicin—ovarian cancer	0.000118	0.000815	CcSEcCtD
Propofol—Feeling abnormal—Docetaxel—ovarian cancer	0.000117	0.000813	CcSEcCtD
Propofol—Tinnitus—Doxorubicin—ovarian cancer	0.000117	0.000808	CcSEcCtD
Propofol—Flushing—Doxorubicin—ovarian cancer	0.000116	0.000804	CcSEcCtD
Propofol—Dysgeusia—Epirubicin—ovarian cancer	0.000115	0.000799	CcSEcCtD
Propofol—Diarrhoea—Paclitaxel—ovarian cancer	0.000115	0.000796	CcSEcCtD
Propofol—Muscle spasms—Epirubicin—ovarian cancer	0.000113	0.000784	CcSEcCtD
Propofol—Body temperature increased—Docetaxel—ovarian cancer	0.000113	0.00078	CcSEcCtD
Propofol—Abdominal pain—Docetaxel—ovarian cancer	0.000113	0.00078	CcSEcCtD
Propofol—Chills—Doxorubicin—ovarian cancer	0.000112	0.000778	CcSEcCtD
Propofol—Arrhythmia—Doxorubicin—ovarian cancer	0.000112	0.000774	CcSEcCtD
Propofol—Dizziness—Paclitaxel—ovarian cancer	0.000111	0.00077	CcSEcCtD
Propofol—Erythema—Doxorubicin—ovarian cancer	0.000109	0.000755	CcSEcCtD
Propofol—Agitation—Epirubicin—ovarian cancer	0.000108	0.000749	CcSEcCtD
Propofol—Vomiting—Paclitaxel—ovarian cancer	0.000107	0.00074	CcSEcCtD
Propofol—Dysgeusia—Doxorubicin—ovarian cancer	0.000107	0.000739	CcSEcCtD
Propofol—Rash—Paclitaxel—ovarian cancer	0.000106	0.000734	CcSEcCtD
Propofol—Dermatitis—Paclitaxel—ovarian cancer	0.000106	0.000733	CcSEcCtD
Propofol—Syncope—Epirubicin—ovarian cancer	0.000106	0.000731	CcSEcCtD
Propofol—Headache—Paclitaxel—ovarian cancer	0.000105	0.000729	CcSEcCtD
Propofol—Muscle spasms—Doxorubicin—ovarian cancer	0.000105	0.000725	CcSEcCtD
Propofol—Loss of consciousness—Epirubicin—ovarian cancer	0.000104	0.000717	CcSEcCtD
Propofol—Cough—Epirubicin—ovarian cancer	0.000103	0.000712	CcSEcCtD
Propofol—Asthenia—Docetaxel—ovarian cancer	0.000102	0.000708	CcSEcCtD
Propofol—Convulsion—Epirubicin—ovarian cancer	0.000102	0.000707	CcSEcCtD
Propofol—Hypertension—Epirubicin—ovarian cancer	0.000102	0.000704	CcSEcCtD
Propofol—Pruritus—Docetaxel—ovarian cancer	0.000101	0.000698	CcSEcCtD
Propofol—Chest pain—Epirubicin—ovarian cancer	0.0001	0.000694	CcSEcCtD
Propofol—Myalgia—Epirubicin—ovarian cancer	0.0001	0.000694	CcSEcCtD
Propofol—Agitation—Doxorubicin—ovarian cancer	0.0001	0.000693	CcSEcCtD
Propofol—Anxiety—Epirubicin—ovarian cancer	0.0001	0.000692	CcSEcCtD
Propofol—Nausea—Paclitaxel—ovarian cancer	9.99e-05	0.000691	CcSEcCtD
Propofol—Dry mouth—Epirubicin—ovarian cancer	9.81e-05	0.000679	CcSEcCtD
Propofol—Syncope—Doxorubicin—ovarian cancer	9.78e-05	0.000677	CcSEcCtD
Propofol—Diarrhoea—Docetaxel—ovarian cancer	9.75e-05	0.000675	CcSEcCtD
Propofol—Confusional state—Epirubicin—ovarian cancer	9.69e-05	0.000671	CcSEcCtD
Propofol—Oedema—Epirubicin—ovarian cancer	9.62e-05	0.000666	CcSEcCtD
Propofol—Anaphylactic shock—Epirubicin—ovarian cancer	9.62e-05	0.000666	CcSEcCtD
Propofol—Loss of consciousness—Doxorubicin—ovarian cancer	9.58e-05	0.000663	CcSEcCtD
Propofol—Cough—Doxorubicin—ovarian cancer	9.51e-05	0.000658	CcSEcCtD
Propofol—Shock—Epirubicin—ovarian cancer	9.46e-05	0.000655	CcSEcCtD
Propofol—Convulsion—Doxorubicin—ovarian cancer	9.44e-05	0.000654	CcSEcCtD
Propofol—Dizziness—Docetaxel—ovarian cancer	9.43e-05	0.000652	CcSEcCtD
Propofol—Hypertension—Doxorubicin—ovarian cancer	9.41e-05	0.000651	CcSEcCtD
Propofol—Tachycardia—Epirubicin—ovarian cancer	9.38e-05	0.00065	CcSEcCtD
Propofol—Hyperhidrosis—Epirubicin—ovarian cancer	9.3e-05	0.000643	CcSEcCtD
Propofol—Chest pain—Doxorubicin—ovarian cancer	9.28e-05	0.000642	CcSEcCtD
Propofol—Myalgia—Doxorubicin—ovarian cancer	9.28e-05	0.000642	CcSEcCtD
Propofol—Anxiety—Doxorubicin—ovarian cancer	9.25e-05	0.00064	CcSEcCtD
Propofol—Dry mouth—Doxorubicin—ovarian cancer	9.08e-05	0.000628	CcSEcCtD
Propofol—Vomiting—Docetaxel—ovarian cancer	9.06e-05	0.000627	CcSEcCtD
Propofol—Rash—Docetaxel—ovarian cancer	8.99e-05	0.000622	CcSEcCtD
Propofol—Hypotension—Epirubicin—ovarian cancer	8.98e-05	0.000622	CcSEcCtD
Propofol—Dermatitis—Docetaxel—ovarian cancer	8.98e-05	0.000622	CcSEcCtD
Propofol—Confusional state—Doxorubicin—ovarian cancer	8.97e-05	0.000621	CcSEcCtD
Propofol—Headache—Docetaxel—ovarian cancer	8.93e-05	0.000618	CcSEcCtD
Propofol—Anaphylactic shock—Doxorubicin—ovarian cancer	8.9e-05	0.000616	CcSEcCtD
Propofol—Oedema—Doxorubicin—ovarian cancer	8.9e-05	0.000616	CcSEcCtD
Propofol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	8.76e-05	0.000606	CcSEcCtD
Propofol—Shock—Doxorubicin—ovarian cancer	8.75e-05	0.000606	CcSEcCtD
Propofol—Insomnia—Epirubicin—ovarian cancer	8.7e-05	0.000602	CcSEcCtD
Propofol—Tachycardia—Doxorubicin—ovarian cancer	8.68e-05	0.000601	CcSEcCtD
Propofol—Paraesthesia—Epirubicin—ovarian cancer	8.63e-05	0.000598	CcSEcCtD
Propofol—Hyperhidrosis—Doxorubicin—ovarian cancer	8.6e-05	0.000595	CcSEcCtD
Propofol—Dyspnoea—Epirubicin—ovarian cancer	8.57e-05	0.000593	CcSEcCtD
Propofol—Somnolence—Epirubicin—ovarian cancer	8.55e-05	0.000592	CcSEcCtD
Propofol—Nausea—Docetaxel—ovarian cancer	8.47e-05	0.000586	CcSEcCtD
Propofol—Hypotension—Doxorubicin—ovarian cancer	8.31e-05	0.000575	CcSEcCtD
Propofol—Fatigue—Epirubicin—ovarian cancer	8.29e-05	0.000574	CcSEcCtD
Propofol—Pain—Epirubicin—ovarian cancer	8.22e-05	0.000569	CcSEcCtD
Propofol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	8.11e-05	0.000561	CcSEcCtD
Propofol—Insomnia—Doxorubicin—ovarian cancer	8.05e-05	0.000557	CcSEcCtD
Propofol—Paraesthesia—Doxorubicin—ovarian cancer	7.99e-05	0.000553	CcSEcCtD
Propofol—Dyspnoea—Doxorubicin—ovarian cancer	7.93e-05	0.000549	CcSEcCtD
Propofol—Feeling abnormal—Epirubicin—ovarian cancer	7.92e-05	0.000548	CcSEcCtD
Propofol—Somnolence—Doxorubicin—ovarian cancer	7.91e-05	0.000547	CcSEcCtD
Propofol—Fatigue—Doxorubicin—ovarian cancer	7.67e-05	0.000531	CcSEcCtD
Propofol—Urticaria—Epirubicin—ovarian cancer	7.64e-05	0.000529	CcSEcCtD
Propofol—Pain—Doxorubicin—ovarian cancer	7.61e-05	0.000527	CcSEcCtD
Propofol—Abdominal pain—Epirubicin—ovarian cancer	7.6e-05	0.000526	CcSEcCtD
Propofol—Body temperature increased—Epirubicin—ovarian cancer	7.6e-05	0.000526	CcSEcCtD
Propofol—Feeling abnormal—Doxorubicin—ovarian cancer	7.33e-05	0.000507	CcSEcCtD
Propofol—Urticaria—Doxorubicin—ovarian cancer	7.07e-05	0.000489	CcSEcCtD
Propofol—Abdominal pain—Doxorubicin—ovarian cancer	7.03e-05	0.000487	CcSEcCtD
Propofol—Body temperature increased—Doxorubicin—ovarian cancer	7.03e-05	0.000487	CcSEcCtD
Propofol—Asthenia—Epirubicin—ovarian cancer	6.9e-05	0.000477	CcSEcCtD
Propofol—Pruritus—Epirubicin—ovarian cancer	6.8e-05	0.000471	CcSEcCtD
Propofol—Diarrhoea—Epirubicin—ovarian cancer	6.58e-05	0.000455	CcSEcCtD
Propofol—Asthenia—Doxorubicin—ovarian cancer	6.38e-05	0.000442	CcSEcCtD
Propofol—Dizziness—Epirubicin—ovarian cancer	6.36e-05	0.00044	CcSEcCtD
Propofol—Pruritus—Doxorubicin—ovarian cancer	6.29e-05	0.000436	CcSEcCtD
Propofol—Vomiting—Epirubicin—ovarian cancer	6.11e-05	0.000423	CcSEcCtD
Propofol—Diarrhoea—Doxorubicin—ovarian cancer	6.09e-05	0.000421	CcSEcCtD
Propofol—Rash—Epirubicin—ovarian cancer	6.06e-05	0.00042	CcSEcCtD
Propofol—Dermatitis—Epirubicin—ovarian cancer	6.06e-05	0.000419	CcSEcCtD
Propofol—Headache—Epirubicin—ovarian cancer	6.02e-05	0.000417	CcSEcCtD
Propofol—Dizziness—Doxorubicin—ovarian cancer	5.88e-05	0.000407	CcSEcCtD
Propofol—Nausea—Epirubicin—ovarian cancer	5.71e-05	0.000395	CcSEcCtD
Propofol—Vomiting—Doxorubicin—ovarian cancer	5.66e-05	0.000392	CcSEcCtD
Propofol—Rash—Doxorubicin—ovarian cancer	5.61e-05	0.000388	CcSEcCtD
Propofol—Dermatitis—Doxorubicin—ovarian cancer	5.6e-05	0.000388	CcSEcCtD
Propofol—Headache—Doxorubicin—ovarian cancer	5.57e-05	0.000386	CcSEcCtD
Propofol—Nausea—Doxorubicin—ovarian cancer	5.28e-05	0.000366	CcSEcCtD
Propofol—CYP2A6—Metabolism—SLC2A1—ovarian cancer	1.1e-05	0.000207	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.1e-05	0.000206	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—YAP1—ovarian cancer	1.06e-05	0.000199	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CYP1B1—ovarian cancer	1.05e-05	0.000198	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.05e-05	0.000198	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—ABCB1—ovarian cancer	1.05e-05	0.000198	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CG—ovarian cancer	1.05e-05	0.000197	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.05e-05	0.000197	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.05e-05	0.000197	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—TYMS—ovarian cancer	1.03e-05	0.000194	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CG—ovarian cancer	1.03e-05	0.000193	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.01e-05	0.000189	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.01e-05	0.000189	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—YAP1—ovarian cancer	9.71e-06	0.000183	CbGpPWpGaD
Propofol—ALB—Metabolism—YAP1—ovarian cancer	9.65e-06	0.000181	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.61e-06	0.000181	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—AKT1—ovarian cancer	9.58e-06	0.00018	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.55e-06	0.00018	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	9.51e-06	0.000179	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.41e-06	0.000177	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	9.36e-06	0.000176	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—FASN—ovarian cancer	9.35e-06	0.000176	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CD—ovarian cancer	9.22e-06	0.000173	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.21e-06	0.000173	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—SLC5A5—ovarian cancer	9.19e-06	0.000173	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—FASN—ovarian cancer	9.15e-06	0.000172	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CD—ovarian cancer	9.03e-06	0.00017	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—SLC5A5—ovarian cancer	9e-06	0.000169	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CAV1—ovarian cancer	8.92e-06	0.000168	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CAV1—ovarian cancer	8.92e-06	0.000168	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYTB—ovarian cancer	8.89e-06	0.000167	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—SLC2A1—ovarian cancer	8.88e-06	0.000167	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—SLC2A1—ovarian cancer	8.7e-06	0.000164	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—ABCB1—ovarian cancer	8.69e-06	0.000163	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—YAP1—ovarian cancer	8.66e-06	0.000163	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—FASN—ovarian cancer	8.63e-06	0.000162	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.58e-06	0.000161	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.57e-06	0.000161	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PIK3CA—ovarian cancer	8.56e-06	0.000161	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—TYMS—ovarian cancer	8.53e-06	0.00016	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.52e-06	0.00016	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CYP1B1—ovarian cancer	8.51e-06	0.00016	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—SLC5A5—ovarian cancer	8.49e-06	0.00016	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.44e-06	0.000159	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.4e-06	0.000158	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CYP1B1—ovarian cancer	8.34e-06	0.000157	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CAV1—ovarian cancer	8.32e-06	0.000156	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—SLC2A1—ovarian cancer	8.2e-06	0.000154	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CG—ovarian cancer	8.12e-06	0.000153	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CG—ovarian cancer	8.12e-06	0.000153	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CB—ovarian cancer	8.04e-06	0.000151	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.03e-06	0.000151	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—YAP1—ovarian cancer	7.97e-06	0.00015	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.95e-06	0.000149	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—FASN—ovarian cancer	7.91e-06	0.000149	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—YAP1—ovarian cancer	7.9e-06	0.000149	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CB—ovarian cancer	7.87e-06	0.000148	CbGpPWpGaD
Propofol—ALB—Metabolism—FASN—ovarian cancer	7.87e-06	0.000148	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CYP1B1—ovarian cancer	7.86e-06	0.000148	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.82e-06	0.000147	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—SLC5A5—ovarian cancer	7.78e-06	0.000146	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.77e-06	0.000146	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.77e-06	0.000146	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	7.77e-06	0.000146	CbGpPWpGaD
Propofol—ALB—Metabolism—SLC5A5—ovarian cancer	7.74e-06	0.000146	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CG—ovarian cancer	7.58e-06	0.000142	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	7.55e-06	0.000142	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.54e-06	0.000142	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—SLC2A1—ovarian cancer	7.52e-06	0.000141	CbGpPWpGaD
Propofol—ALB—Metabolism—SLC2A1—ovarian cancer	7.47e-06	0.000141	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	7.39e-06	0.000139	CbGpPWpGaD
Propofol—ALB—Hemostasis—IL2—ovarian cancer	7.38e-06	0.000139	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.36e-06	0.000138	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.33e-06	0.000138	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.32e-06	0.000138	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP1B1—ovarian cancer	7.21e-06	0.000136	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP1B1—ovarian cancer	7.17e-06	0.000135	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CD—ovarian cancer	7.14e-06	0.000134	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CD—ovarian cancer	7.14e-06	0.000134	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—FASN—ovarian cancer	7.06e-06	0.000133	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ABCB1—ovarian cancer	7.01e-06	0.000132	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—AKT1—ovarian cancer	6.99e-06	0.000131	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	6.97e-06	0.000131	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SLC5A5—ovarian cancer	6.95e-06	0.000131	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.94e-06	0.00013	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—TYMS—ovarian cancer	6.88e-06	0.000129	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CAV1—ovarian cancer	6.88e-06	0.000129	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.87e-06	0.000129	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ABCB1—ovarian cancer	6.87e-06	0.000129	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTEN—ovarian cancer	6.8e-06	0.000128	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—YAP1—ovarian cancer	6.75e-06	0.000127	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—TYMS—ovarian cancer	6.74e-06	0.000127	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SLC2A1—ovarian cancer	6.71e-06	0.000126	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.68e-06	0.000126	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CD—ovarian cancer	6.66e-06	0.000125	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.57e-06	0.000124	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—FASN—ovarian cancer	6.5e-06	0.000122	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ABCB1—ovarian cancer	6.47e-06	0.000122	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—FASN—ovarian cancer	6.44e-06	0.000121	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP1B1—ovarian cancer	6.43e-06	0.000121	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	6.39e-06	0.00012	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SLC5A5—ovarian cancer	6.39e-06	0.00012	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.36e-06	0.00012	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—TYMS—ovarian cancer	6.36e-06	0.00012	CbGpPWpGaD
Propofol—ALB—Metabolism—PPP2R1A—ovarian cancer	6.35e-06	0.00012	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SLC5A5—ovarian cancer	6.33e-06	0.000119	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.32e-06	0.000119	CbGpPWpGaD
Propofol—ALB—Hemostasis—VEGFA—ovarian cancer	6.27e-06	0.000118	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CG—ovarian cancer	6.26e-06	0.000118	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CB—ovarian cancer	6.23e-06	0.000117	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CB—ovarian cancer	6.23e-06	0.000117	CbGpPWpGaD
Propofol—ALB—Hemostasis—NRAS—ovarian cancer	6.2e-06	0.000117	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SLC2A1—ovarian cancer	6.17e-06	0.000116	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SLC2A1—ovarian cancer	6.12e-06	0.000115	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.99e-06	0.000113	CbGpPWpGaD
Propofol—ALB—Hemostasis—MAPK3—ovarian cancer	5.94e-06	0.000112	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ABCB1—ovarian cancer	5.93e-06	0.000112	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP1B1—ovarian cancer	5.92e-06	0.000111	CbGpPWpGaD
Propofol—ALB—Metabolism—ABCB1—ovarian cancer	5.9e-06	0.000111	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.87e-06	0.00011	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP1B1—ovarian cancer	5.87e-06	0.00011	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—TYMS—ovarian cancer	5.83e-06	0.00011	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CB—ovarian cancer	5.81e-06	0.000109	CbGpPWpGaD
Propofol—ALB—Metabolism—TYMS—ovarian cancer	5.8e-06	0.000109	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	5.7e-06	0.000107	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.68e-06	0.000107	CbGpPWpGaD
Propofol—ALB—Hemostasis—MAPK1—ovarian cancer	5.65e-06	0.000106	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CAV1—ovarian cancer	5.55e-06	0.000104	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CD—ovarian cancer	5.51e-06	0.000104	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—FASN—ovarian cancer	5.5e-06	0.000103	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CAV1—ovarian cancer	5.43e-06	0.000102	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SLC5A5—ovarian cancer	5.41e-06	0.000102	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTEN—ovarian cancer	5.38e-06	0.000101	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTEN—ovarian cancer	5.38e-06	0.000101	CbGpPWpGaD
Propofol—ALB—Hemostasis—KRAS—ovarian cancer	5.33e-06	0.0001	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ABCB1—ovarian cancer	5.3e-06	9.96e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	5.25e-06	9.87e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SLC2A1—ovarian cancer	5.23e-06	9.83e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—YAP1—ovarian cancer	5.21e-06	9.8e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—TYMS—ovarian cancer	5.2e-06	9.78e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	5.2e-06	9.78e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.18e-06	9.73e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CAV1—ovarian cancer	5.12e-06	9.63e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.12e-06	9.63e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CG—ovarian cancer	5.05e-06	9.5e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTEN—ovarian cancer	5.02e-06	9.43e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP1B1—ovarian cancer	5.01e-06	9.43e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CG—ovarian cancer	4.95e-06	9.31e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CA—ovarian cancer	4.9e-06	9.22e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.89e-06	9.2e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ABCB1—ovarian cancer	4.87e-06	9.16e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.83e-06	9.08e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CA—ovarian cancer	4.8e-06	9.03e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CB—ovarian cancer	4.8e-06	9.02e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—TYMS—ovarian cancer	4.78e-06	9e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—TYMS—ovarian cancer	4.74e-06	8.92e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—ovarian cancer	4.74e-06	8.92e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CAV1—ovarian cancer	4.7e-06	8.83e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—CAV1—ovarian cancer	4.67e-06	8.78e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CG—ovarian cancer	4.67e-06	8.78e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—HRAS—ovarian cancer	4.53e-06	8.53e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.49e-06	8.44e-05	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.46e-06	8.39e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	4.44e-06	8.36e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CD—ovarian cancer	4.44e-06	8.35e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.42e-06	8.32e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CD—ovarian cancer	4.35e-06	8.18e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CG—ovarian cancer	4.28e-06	8.05e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CG—ovarian cancer	4.25e-06	8e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—FASN—ovarian cancer	4.25e-06	7.99e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CAV1—ovarian cancer	4.19e-06	7.88e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.18e-06	7.86e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTEN—ovarian cancer	4.15e-06	7.8e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ABCB1—ovarian cancer	4.13e-06	7.76e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CD—ovarian cancer	4.1e-06	7.71e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—TYMS—ovarian cancer	4.05e-06	7.62e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.03e-06	7.59e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4e-06	7.53e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—AKT1—ovarian cancer	4e-06	7.53e-05	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—AKT1—ovarian cancer	3.92e-06	7.38e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CB—ovarian cancer	3.87e-06	7.28e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.87e-06	7.27e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CAV1—ovarian cancer	3.86e-06	7.25e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CAV1—ovarian cancer	3.82e-06	7.19e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CG—ovarian cancer	3.82e-06	7.18e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CA—ovarian cancer	3.79e-06	7.14e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CA—ovarian cancer	3.79e-06	7.14e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CB—ovarian cancer	3.79e-06	7.13e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CD—ovarian cancer	3.76e-06	7.07e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CD—ovarian cancer	3.74e-06	7.03e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.65e-06	6.87e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CB—ovarian cancer	3.58e-06	6.72e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CA—ovarian cancer	3.54e-06	6.66e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.51e-06	6.6e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.48e-06	6.55e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.43e-06	6.45e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.36e-06	6.31e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTEN—ovarian cancer	3.35e-06	6.29e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.28e-06	6.16e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTEN—ovarian cancer	3.28e-06	6.16e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CAV1—ovarian cancer	3.27e-06	6.14e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CB—ovarian cancer	3.26e-06	6.13e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.19e-06	5.99e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—TYMS—ovarian cancer	3.13e-06	5.88e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.12e-06	5.87e-05	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—AKT1—ovarian cancer	3.1e-06	5.83e-05	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—AKT1—ovarian cancer	3.1e-06	5.83e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTEN—ovarian cancer	3.09e-06	5.81e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CD—ovarian cancer	3.09e-06	5.81e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.06e-06	5.76e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.98e-06	5.6e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.93e-06	5.5e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CA—ovarian cancer	2.93e-06	5.5e-05	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—AKT1—ovarian cancer	2.89e-06	5.44e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTEN—ovarian cancer	2.83e-06	5.33e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PTEN—ovarian cancer	2.82e-06	5.3e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.69e-06	5.06e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.67e-06	5.02e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.62e-06	4.92e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTEN—ovarian cancer	2.53e-06	4.75e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CAV1—ovarian cancer	2.52e-06	4.74e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AKT1—ovarian cancer	2.39e-06	4.49e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CA—ovarian cancer	2.36e-06	4.44e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTEN—ovarian cancer	2.33e-06	4.37e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CA—ovarian cancer	2.31e-06	4.35e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTEN—ovarian cancer	2.31e-06	4.34e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.3e-06	4.32e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.28e-06	4.29e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CA—ovarian cancer	2.18e-06	4.1e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.02e-06	3.8e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2e-06	3.76e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CA—ovarian cancer	1.99e-06	3.74e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTEN—ovarian cancer	1.97e-06	3.7e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AKT1—ovarian cancer	1.93e-06	3.63e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AKT1—ovarian cancer	1.89e-06	3.55e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.78e-06	3.35e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AKT1—ovarian cancer	1.78e-06	3.35e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.76e-06	3.31e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.64e-06	3.09e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AKT1—ovarian cancer	1.63e-06	3.07e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.63e-06	3.06e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—AKT1—ovarian cancer	1.62e-06	3.05e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTEN—ovarian cancer	1.52e-06	2.86e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AKT1—ovarian cancer	1.46e-06	2.74e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.39e-06	2.61e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AKT1—ovarian cancer	1.34e-06	2.52e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AKT1—ovarian cancer	1.33e-06	2.5e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AKT1—ovarian cancer	1.14e-06	2.14e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.07e-06	2.02e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AKT1—ovarian cancer	8.76e-07	1.65e-05	CbGpPWpGaD
